RESTON, Va., Sept. 16, 2016 /PRNewswire/ -- Leidos (NYSE: LDOS), a science and technology solutions company, was awarded a prime contract by the U.S. Army Space and Missile Defense Command to provide technical solutions in support of the Counter-Narcoterrorism Technology Program Office (CNTPO). The multiple-award indefinite-delivery/indefinite-quantity contract has a two-year base period of performance, two option years, and a total programmatic contract ceiling of approximately $480 million for all awardees, if all options are exercised. Leidos is one of four contractors eligible to compete for work under the contract.
The CNPTO develops technology for interagency and multinational operations to disrupt, deter, and deny narcoterrorist activities in an effort to reduce trafficking in illegal narcotics and materials that support global terrorist activities. Under the contract, Leidos will provide technical solutions and mission support, for command, control, communications, information, detection and monitoring technology and systems to disrupt and degrade the national security threats posed by drug trafficking, piracy, transnational organized crime, and threat finance networks reasonably related to illicit drug trafficking activities.
"We're proud to apply our advanced technical solutions in support of the Counter-Narcoterrorism Technology Program Office to stem the flow of international drug trafficking," said Leidos Group President, John Fratamico.
About Leidos
Leidos is a global science and technology solutions leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 33,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported pro forma annual revenues of approximately $10 billion for the fiscal year ended Jan. 1, 2016 after giving effect to the recently completed combination of Leidos with Lockheed Martin's Information Systems & Global Solutions business (IS&GS). For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended January 1, 2016, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.
Contact: |
Melissa Koskovich |
Rashi Ratan |
(571) 526-6850 |
(571) 526-7781 |
|
Logo - http://http://photos.prnewswire.com/prnh/20131120/PH20896LOGO
SOURCE Leidos
Share this article